Assembly Biosciences's total assets for Q1 2026 were $235.51M, a decrease of -8.57% from the previous quarter. ASMB total liabilities were $36.90M for the fiscal quarter, a -27.42% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.